Dr. David Shahriar Kamrava, MD

Dr. Kamrava practices at UCLA West Valley Medical Center in West Hills, California, part of University of California Health.

Dr. Kamrava's NPI, 1285800359, was assigned on May 7, 2008. Dr. Kamrava graduated from St. George's University School of Medicine in 2005. Dr. Kamrava holds California license A102042.

Dr. Kamrava's primary practice is UCLA West Valley Medical Center, at 7300 Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 676-4000.

Dr. Kamrava's primary practice is UCLA West Valley Medical Center in West Hills, California, part of University of California Health. Dr. Kamrava is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Partner Medical Group. Dmand AI also links Dr. Kamrava to 3 more hospitals, 1 physician office, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamrava practices, 8 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kamrava's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kamrava is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kamrava's licenses on file in 2 states: California and Arizona.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis and pleural effusion among the conditions Dr. Kamrava treats.

CMS data shows 5,934 Medicare services from Dr. Kamrava across 24 procedure codes in 2024, for 997 Medicare patients. Medicare paid $743,623 for them.

CMS counts 997 Medicare patients who saw Dr. Kamrava in 2024. The largest group is 75 to 84, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamrava's median patient age at 74, with 49% women.

In 2024, Dr. Kamrava wrote 2,624 Medicare Part D claims for 312 patients. 65% of them were for generic drugs. CMS names the drug for 2,174 of them, across 54 drugs with 11 or more claims each, at $640,043 in total drug cost. In 2023, CMS named 1,633 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kamrava for performance year 2024, reported individually. Dr. Kamrava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kamrava as offering telehealth.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 639 general payments to Dr. Kamrava from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $28,466.

Dr. Kamrava graduated from St. George's University School of Medicine in 2005.

Dr. Kamrava is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.